Curanex Pharmaceuticals Inc (CURX)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $6.21
- As of
Kresmion compiles this page from CURX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Curanex Pharmaceuticals Inc (CURX): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-19.
See the full CURX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for CURX on one page. Preview it with sample data, then open it live with a free account.
Preview the CURX dossierActive events for CURX
- high13F: large reduction
TWO SIGMA INVESTMENTS, LP cut 67% of CURX (2026Q1)
FREE, NO ACCOUNT
Every event on CURX, as it fires
New filings, 13F moves and cross asset events on CURX land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
CURX positions held by the managers we follow (2026Q2)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| CITADEL ADVISORS LLC FundCUSIP 23126K106 · 2026Q2 | $25K | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC FundCUSIP 23126K106 · 2026Q2 | $14K | 0.00% |
| TWO SIGMA INVESTMENTS, LP FundCUSIP 23126K106 · 2026Q2 | $7K | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, CURX
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
CURX's 10-Q filed Aug 14, 2026 states:
These conditions raise substantial doubt about our ability to continue as a going concern.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on CURX
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in CURX on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on CURX in the last 180 days.
Upstream: SEC EDGAR filings for CURX
Kresmion, "Curanex Pharmaceuticals Inc (CURX) institutional holdings and SEC filings", data as of 2026-10-19, https://kresmion.com/research/CURX. Upstream data: SEC EDGAR filings for CURX.
Link to this data (HTML):
<a href="https://kresmion.com/research/CURX">Curanex Pharmaceuticals Inc (CURX) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow CURX on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to CURX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.